Literature DB >> 26022262

The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use.

Erica J Young, Sherri B Briggs, Courtney A Miller1.   

Abstract

A high rate of relapse is a defining characteristic of substance use disorder for which few treatments are available. Exposure to environmental cues associated with previous drug use can elicit relapse by causing the involuntary retrieval of deeply engrained associative memories that trigger a strong motivation to seek out drugs. Our lab is focused on identifying and disrupting mechanisms that support these powerful consolidated memories, with the goal of developing therapeutics. A particularly promising mechanism is regulation of synaptic dynamics by actin polymerization within dendritic spines. Emerging evidence indicates that memory is supported by structural and functional plasticity dendritic spines, for which actin polymerization is critical, and that prior drug use increases both spine and actin dynamics. Indeed we have found that inhibiting amygdala (AMY) actin polymerization immediately or twenty-four hours prior to testing disrupted methamphetamine (METH)-associated memories, but not food reward or fear memories. Furthermore, METH training increased AMY spine density which was reversed by actin depolymerization treatment. Actin dynamics were also shifted to a more dynamic state by METH training. While promising, actin polymerization inhibitors are not a viable therapeutic, as a multitude of peripheral process (e.g. cardiac function) rely on dynamic actin. For this reason, we have shifted our focus upstream of actin polymerization to nonmuscle myosin II. We and others have demonstrated that myosin IIb imparts a mechanical force that triggers spine actin polymerization in response to synaptic stimulation. Similar to an actin depolymerizing compound, pre-test inhibition of myosin II ATPase activity in the AMY produced a rapid and lasting disruption of drug-seeking behavior. While many questions remain, these findings indicate that myosin II represents a potential therapeutic avenue to target the actin cytoskeleton and disrupt the powerful, extinction-resistant memories capable of triggering relapse.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26022262      PMCID: PMC4641563          DOI: 10.2174/1871527314666150529145531

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  75 in total

1.  A role of actin filament in synaptic transmission and long-term potentiation.

Authors:  C H Kim; J E Lisman
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

Review 2.  Role of myosin II in axon outgrowth.

Authors:  Jacquelyn Brown; Paul C Bridgman
Journal:  J Histochem Cytochem       Date:  2003-04       Impact factor: 2.479

3.  Non-muscle myosin IIB-like immunoreactivity is present at the drebrin-binding cytoskeleton in neurons.

Authors:  X T Cheng; K Hayashi; T Shirao
Journal:  Neurosci Res       Date:  2000-02       Impact factor: 3.304

4.  Distinct roles of hippocampal de novo protein synthesis and actin rearrangement in extinction of contextual fear.

Authors:  André Fischer; Farahnaz Sananbenesi; Christina Schrick; Joachim Spiess; Jelena Radulovic
Journal:  J Neurosci       Date:  2004-02-25       Impact factor: 6.167

5.  Altered Fos expression in neural pathways underlying cue-elicited drug seeking in the rat.

Authors:  Courtney A Miller; John F Marshall
Journal:  Eur J Neurosci       Date:  2005-03       Impact factor: 3.386

Review 6.  Structural dynamics of dendritic spines in memory and cognition.

Authors:  Haruo Kasai; Masahiro Fukuda; Satoshi Watanabe; Akiko Hayashi-Takagi; Jun Noguchi
Journal:  Trends Neurosci       Date:  2010-03       Impact factor: 13.837

Review 7.  The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments.

Authors:  Amy L Milton; Barry J Everitt
Journal:  Neurosci Biobehav Rev       Date:  2012-01-24       Impact factor: 8.989

8.  Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

Authors:  Jeffrey W Grimm; Lin Lu; Teruo Hayashi; Bruce T Hope; Tsung-Ping Su; Yavin Shaham
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

9.  Stably maintained dendritic spines are associated with lifelong memories.

Authors:  Guang Yang; Feng Pan; Wen-Biao Gan
Journal:  Nature       Date:  2009-11-29       Impact factor: 49.962

10.  Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference.

Authors:  Melissa Malvaez; Carles Sanchis-Segura; Darren Vo; K Matthew Lattal; Marcelo A Wood
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

View more
  13 in total

Review 1.  Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

Authors:  April L Risinger; Lin Du
Journal:  Nat Prod Rep       Date:  2019-11-25       Impact factor: 13.423

Review 2.  Neuropsychiatric Model of Addiction Simplified.

Authors:  Wilson M Compton; Eric M Wargo; Nora D Volkow
Journal:  Psychiatr Clin North Am       Date:  2022-07-31

3.  Circadian transcription factor NPAS2 and the NAD+ -dependent deacetylase SIRT1 interact in the mouse nucleus accumbens and regulate reward.

Authors:  Darius D Becker-Krail; Puja K Parekh; Kyle D Ketchesin; Shintaro Yamaguchi; Jun Yoshino; Mariah A Hildebrand; Brandan Dunham; Madhavi K Ganapathiraju; Ryan W Logan; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2022-01-20       Impact factor: 3.698

4.  Methamphetamine Learning Induces Persistent and Selective Nonmuscle Myosin II-Dependent Spine Motility in the Basolateral Amygdala.

Authors:  Erica J Young; Hua Lin; Theodore M Kamenecka; Gavin Rumbaugh; Courtney A Miller
Journal:  J Neurosci       Date:  2020-02-17       Impact factor: 6.167

Review 5.  Neuromechanobiology: An Expanding Field Driven by the Force of Greater Focus.

Authors:  Cara T Motz; Victoria Kabat; Tarun Saxena; Ravi V Bellamkonda; Cheng Zhu
Journal:  Adv Healthc Mater       Date:  2021-08-02       Impact factor: 11.092

6.  Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region.

Authors:  Sherri B Briggs; Ashley M Blouin; Erica J Young; Gavin Rumbaugh; Courtney A Miller
Journal:  Learn Mem       Date:  2017-01-17       Impact factor: 2.460

7.  The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.

Authors:  Sherri B Briggs; Madalyn Hafenbreidel; Erica J Young; Gavin Rumbaugh; Courtney A Miller
Journal:  Learn Mem       Date:  2018-08-16       Impact factor: 2.460

8.  Methamphetamine-associated cognitive decline is attenuated by neutralizing IL-1 signaling.

Authors:  Arkadiusz Liśkiewicz; Marta Przybyła; Minseon Park; Daniela Liśkiewicz; Marta Nowacka-Chmielewska; Andrzej Małecki; Jarosław Barski; Joanna Lewin-Kowalik; Michal Toborek
Journal:  Brain Behav Immun       Date:  2019-03-15       Impact factor: 7.217

9.  Inhibition of actin polymerization in the NAc shell inhibits morphine-induced CPP by disrupting its reconsolidation.

Authors:  Gongying Li; Yanmei Wang; Min Yan; Yunshuai Xu; Xiuli Song; Qingqing Li; Jinxiang Zhang; Hongxia Ma; Yili Wu
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

10.  PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains.

Authors:  Naresh Damuka; Paul W Czoty; Ashley T Davis; Michael A Nader; Susan H Nader; Suzanne Craft; Shannon L Macauley; Lindsey K Galbo; Phillip M Epperly; Christopher T Whitlow; April T Davenport; Thomas J Martin; James B Daunais; Akiva Mintz; Kiran Kumar Solingapuram Sai
Journal:  Molecules       Date:  2020-05-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.